KONE's share capital increases through subscription of shares with
2005A, 2005B and 2005C option rights
April 30, 2008 02:19 ET
|
KONE Oyj
KONE Corporation, stock exchange announcement, April 30, 2008
A total of 138,480 new KONE class B shares have been subscribed for
with 2005A option rights, a total of 43,512 new KONE class B...
Genmab's Total Number of Voting Rights and Total Share Capital
April 30, 2008 02:18 ET
|
Genmab A/S
Summary: Notification according to the Executive Order on Issuers' Disclosure
Obligations
Copenhagen, Denmark; April 30,...
Decision of Market Services Department (as of 30-04-2008, No.111)
April 30, 2008 02:12 ET
|
Nasdaq Vilnius
To resume trading of these financial instruments on 30-04-2008:
Vilniaus baldai ORS (LT0000104267 VBL1L)
At the shareholders' meeting it was decided to approve the annual accounts.
Vilnius...
Vilniaus baldai AB resolutions of the annual general meeting
April 30, 2008 02:07 ET
|
Vilniaus baldai
DECISIONS TAKEN AT THE GENERAL MEETING OF SHAREHOLDERS HELD ON 29/04/2008
The following decisions were taken at the General Meeting of Shareholders of
AB “Vilniaus Baldai” which was held on the...
AstraZeneca lämnar in ansökan om utökad indikation för användning av Symbicort® vid KOL
April 30, 2008 02:03 ET
|
AstraZeneca PLC
AstraZeneca lämnar in ansökan om utökad indikation för användning av Symbicort®
vid KOL
AstraZeneca meddelade idag att en ansökan inlämnats om utökad indikation (sNDA)
till den amerikanska...
DGAP-NVR: Schmack Biogas AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
April 30, 2008 02:02 ET
|
EQS Group AG
Schmack Biogas AG / Total Voting Rights announcement
30.04.2008
Total Voting Rights announcement according to Article 26a of the...
OXiGENE Announces Preclinical Data Demonstrating that the Active Metabolite of ZYBRESTAT Improves Glucose Metabolism through Similar Mechanism as a Sirtuin Agonist
April 30, 2008 02:00 ET
|
Oxigene, Inc.
OXiGENE Announces Preclinical Data Demonstrating that the Active Metabolite of
ZYBRESTAT Improves Glucose Metabolism through Similar Mechanism as a Sirtuin
Agonist
Combretastatin-A4 and Its Analog,...
Regnskabsmeddelelse for perioden 1. januar til 31. marts 2008
April 30, 2008 02:00 ET
|
Novo Nordisk A/S
Novo Nordisks salg steg med 15% opgjort i lokale valutaer og som følge af en betydelig negativ valutakursudvikling med 8% opgjort i kroner....
Regnskabsmeddelelse for perioden 1. januar til 31. marts 2008
April 30, 2008 02:00 ET
|
Novo Nordisk A/S
Novo Nordisks resultat af primær drift i første kvartal steg med 22%
Bruttomarginen steg med 0,9 procentpoint trods negativ
valutakursudvikling
* Novo Nordisks salg steg med 15% opgjort i...
1st Quarter Results
April 30, 2008 02:00 ET
|
Novo Nordisk A/S
Financial statement for the period 1 January 2008 to 31 March 2008
Novo Nordisk increased first quarter operating profit by 22%
Gross margin improved by 0.9 percentage points, despite...
- January 24, 2025 16:52 ET Arhaus Opens Showroom in Winter Park, Florida
- January 24, 2025 16:51 ET DMC Global Inc. Stockholders Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Class Action Against BOOM